header

ReSHAPE PUBLICATIONS

  • Léa Flippe, Séverine Bézie, Ignacio Anegon,vCarole Guillonneau.
    Future prospects for CD8+ regulatory T cells in immune tolerance.
    Immunological reviews, 2019, 292, 1-16, DOI: 10.1111/imr.12812
  • Séverine Ménoret, Laure-Hélène Ouisse, Laurent Tesson, Séverine Remy, Claire Usal, Aude Guiffes, Vanessa Chenouard, Pierre-Joseph Royer, Gwenaelle Evanno, Bernard Vanhove, Eliane Piaggio, and Ignacio Anegon.
    In vivo analysis of human immune responses in immunodeficient rats.
    Transplantation, in press
  • George Adigbli, Séverine Ménoret, Amy R Cross, Joanna Hester, Fadi Issa, Ignacio Anegon.
    Humanization of immunodeficient animals for the modelling of transplantation, graft-versus host disease and regenerative medicine.
    Transplantation, in press
  • Enrico Fritsche, Hans-Dieter, Volk Petra Reinke, Mohamed Abou-El-Enein.
    Toward an optimized process for clinical manufacturing of chimeric antigen receptor regulatory T-cell therapy (CAR-Treg) Trends in Biotechnology.
    Cell Press, manuscript submitted
  • Enrico Fritsche, Magdi Elsallab, Michaela Schaden,Spencer Phillips Hey, Mohamed Abou-El-Enein.
    ost-marketing safety and efficacy surveillance of cell and gene therapies in the EU: A critical review.
    Cell & Gene Therapy Insights, 2019; 5(11), 1505–1521, DOI: 10.18609/cgti.2019.156

ReSHAPE CONFERENCES

Type Researcher(s) involved Event (Title, location, dates) Activity title
(e.g. title of poster or talk, etc.)
Type of audience Estimated persons reached
Participation to a conference P1-CHARITE: L. Amini, Schmueck-Henneresse 1ST IMMUNOLOGY & INFLAMMATION CONFERENCE, 24. - 26.02. 2019 Immunosuppressant-resistant T cells for advanced adoptive T cell therapy in immunosuppressed patients Scientific Community (Higher Education, Research) >1000
Participation to an event other than a conference or workshop P1- CHARITE: P. Reinke British German Alliance for Advanced Therapies, British Embassy, Berlin (Germany), 26.03.2019 ReSHAPE by next generation Treg approaches - An EU Consortium coordinated by BeCAT Policy Makers 53
Participation in activities organised jointly with other H2020 project(s) P1- CHARITE: H.-D. Volk; P. Reinke Kick-off meeting of the RESTORE community, Berlin (Germany), 06.-07.05.2019 Promoting Advanced therapies and strenghten the development of Advanced Therapies in the European market Other >320
Participation to a conference P1- CHARITE: L. Amini, Schmueck-Henneresse Allogenic Cell Therapies Summit, 7.-9.05.2019 Antiviral and CAR-T cell products for advanced adoptive T cell therapy Scientific Community (Higher Education, Research) >100
Participation to a conference P1- CHARITE: P. Reinke; J. Wendering; L.Amini FOCIS Annual Meeting 2019, Boston (US), 18.-21.06.2019 Next-Generation Regulatory T Cell Therapy; The Value of a Rapid Test of Huamn Regulatory T Cell Function Needs to be Revised (poster) Scientific Community (Higher Education, Research) >1060
Participation to a conference P1- CHARITE: L. Amini Cell & Gene Therapy Bioprocessing & Commercialization, 9.-12.09.2019   Investors >2000
Participation to a conference P1- CHARITE: P. Reinke Phacilitate Leader Europe 2019, London (UK), 17.-18.09.2019 RESTORE/RESHAPE faces challenges in manufacturing of Advanced Therapies Scientific Community (Higher Education, Research) >350
Participation to a conference P1- CHARITE: P. Reinke; L.Amini 7th Annual Conference of the German Stem Cell Network, Berlin (Germany), 23.-25.09.2019 Next-generation regulatory T cell products - opportunities and challenges Scientific Community (Higher Education, Research) >400
Participation to an event other than a conference or workshop P1- CHARITE: P. Reinke Promoting Translational Research in University Medicine, Berlin (Germang), 08.12.2019 Early clinical trials with ATMPs Scientific Community (Higher Education, Research) >100
Participation to an event other than a conference or workshop P1- CHARITE: P. Reinke; N. M. Otto, Schmueck-Henneresse RegMed Forum 2019: cell and gene therapies, Berlin (Germany), 22.10.2019 Regulatory T cells: A treatment option for balancing immune responses; Regulatory T cell therapy in solid organ transplantation; Other >120
Participation in activities organised jointly with other H2020 project(s) P1- CHARITE: H.-D. Volk; P. Reinke; L. Amini, Schmueck-Henneresse RESTORE: 1st Advanced Therapy Science Meeting, Berlin (Germany), 25.-26.11.2019 RESTORE - Health by Advanced Therapies - Opportunities and Challenges; Reshape immune balance by next-generation regulatory T cells; Other 400
Participation to a conference P1- CHARITE: Julia Polansky-Biskup RESTORE: 1st Advanced Therapy Science Meeting, Berlin (Germany), 25.-26.11.2019 invited talk: Epigenetic control of T cell differentiation: From genome-wide signatures to local regulators and their targeted manipulation. Scientific Community (Higher Education, Research) 400
Participation to a conference P1- CHARITE: L. Amini, Schmueck-Henneresse The Hitchhiker’s Guide to Regenerative Therapies, 03.-06.12.2019 Immunosuppressant-resistant antiviral and regulatory T cell products for advanced adoptive T cell therapy in immunosuppressed patients Scientific Community (Higher Education, Research) >100
Participation to a conference P4-UOXF: Fadi Issa "Nanostring EU Summits: Crosstalk" 23 Oct 2019, Birmingham, UK "How nanoString can enrich transplant studies" - talk Scientific Community (Higher Education, Research) 100
Participation to a conference P4-UOXF: Fadi Issa International Transplantation Science Meeting, 10 - 13th November 2019, Clearwater Beach, Florida, USA   Scientific Community (Higher Education, Research) 200
Participation to an event other than a conference or workshop P4-UOXF: Joanna Hester RESTORE: 1st Advanced Therapy Science Meeting, Berlin (Germany), 25.-26.11.2019 "The TWO Study – A Phase II Trial of Regulatory T Cell Therapy in Renal Transplantation" - poster Scientific Community (Higher Education, Research) 400
Participation to a conference P4-UOXF: Fadi Issa The 4th International Workshop on Clinical Tolerance Update on the Oxford/London ONE and TWO Studies Scientific Community (Higher Education, Research) 100
Participation to an event other than a conference or workshop P5-Markus Templin Virologisch-wissenschaftliches Kolloquium University Clinic Tübingen Germany Talk: Multiplexed Immunoassays - Characterisation of Immune Cells Scientific Community (Higher Education, Research) 60
Participation to an event other than a conference or workshop P6- CTC: Ilaria Santeramo CGTC's regular lab meeting, CGTC, 21 August 2019 Internal talk Scientific Community (Higher Education, Research) 50
Participation to a conference P10-Ignacio Anegon FOCISed in South East Asia 1st Annual Course: Advances in Immunology, Immune Monitoring, and Immunotherapy. Jaipur, India. March 26-29, 2019. talk Scientific Community (Higher Education, Research) 120
Participation to a conference P10- UN Ignacio Anegon Latin American Society for Immunology and French Society for Immunology joint meeting. FOCIS annual meeting. Cancun, Mexico. June 18th 2019. I. Anegon. CD8+ Tregs in transplantation. talk Scientific Community (Higher Education, Research) 100
Participation to a conference P10- UN Carole Guillonneau 3) Day of Immunotechnologies, Institut Gustave Roussy, Paris, France. 26th Septembre 2019. C. Guillonneau, Anti-CD45RC to eliminate Teffs and induce Tregs in transplantation and autoimmune diseases talk Scientific Community (Higher Education, Research) 150
Participation to a conference P10- UN Carole Guillonneau ThymE: T cell and thymus biology, Rehovot, Israel 19-23 May 2019. C. Guillonneau, Anti-CD45RC to eliminate Teffs and induce Tregs in APECED disease. talk    
Participation to a conference P10- UN What’s up in Immunotherapy, 31st January 2019, C. Guillonneau, Nantes, France. Anti-CD45RC to eliminate Teffs and induce Tregs in transplantation and autoimmune diseases. talk    
Participation to a conference P10- UN Séverine Bézie ThymE: T cell and thymus biology. Rehovot, Israel, 19-23 May 2019. S. Bézie (poster) Human CD8+ Treg mediated inhibition of GVHD and human skin rejection in NSG mice.      
Participation to a conference P10- UN Carole Guillonneau Annual Meeting of the French Society for Immunology, Nantes, France. 12-14rd November 2019 oral presentation, title: Anti-CD45RC to eliminate Teffs and induce Tregs in transplantation and autoimmune diseases.    
Participation to a conference P10- UN Séverine Bézie Annual Meeting of the French Society for Immunology, Nantes, France. 12-14th November 2019 Oral presentation, title: Human CD8+ Treg suppress human skin rejection and GVHD in NSG mice.    

ReSHAPE PRESS RELEASES


Press releases and other dissemination material will be available soon.